Tag: #Global Trends

What This Means for the Future of Precision Oncology? Roche has announced positive topline results from the Phase III Krascendo-1... Read more

Key Development Global biopharmaceutical aggregator AstraZeneca has formally entered into a definitive strategic collaboration and exclusive licensing agreement valued at... Read more

Key Development Global biopharmaceutical innovator Sanofi has officially released positive top-line data from its pivotal Phase III Baby-COMET clinical trial... Read more

Key Development Global biopharmaceutical leader Eli Lilly has formally executed a definitive strategic agreement transferring the mainland China commercialization rights... Read more

Key Development The chair of the U.S. House Select Committee on the Strategic Competition Between the United States and the... Read more

Key Development The chair of the U.S. House Select Committee on the Strategic Competition Between the United States and the... Read more

Key Development Biopharmaceutical aggregators AbbVie and Genmab have jointly released positive top-line data from their definitive Phase III Epcore DLBCL-4... Read more

Key Development Global biopharmaceutical enterprise AstraZeneca has formally agreed to a $34 million financial settlement to resolve a high-profile civil... Read more

Key Development AstraZeneca, through its core rare disease operational arm Alexion, has officially unveiled detailed high-level data from its pivotal... Read more